Published in Managed Care Business Week, October 12th, 2004
The study is the first to document decreases in the neurotransmitter dopamine in those with the condition, and may lead to new, more effective therapies. HIV dementia is a type of cognitive decline that is more common in the later stages of HIV infection.
"Our results offer the first evidence of dopamine terminal injury - specifically injury to dopamine transporters - in HIV dementia patients," said Brookhaven physician Gene-Jack Wang, the study's lead author. "This...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week